| Fund ID | 805-2112956740 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | No |
| Prepared per GAAP | No |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 40% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Solas Bioventures Emerging Healthcare Fund, LP | Venture Capital | $51.9M |
| Solas Bioventures Fund II, LP | Venture Capital | $34.3M |
| Solas Francis Sidecar | Venture Capital | $24.5M |
Solas Vesalio Sidecar reports $8.1 million in gross assets, among the top 80% of private funds by size.
Solas Vesalio Sidecar is managed by Solas Bioventures Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.